Promising stratagems for reducing the burden of neonatal sepsis.
Modi
N
N
Division of Paediatrics and Neonatal Medicine, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK. n.modi@ic.ac.uk
Carr
R
R
D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D018849:Controlled Clinical Trials as Topic; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007231:Infant, Newborn; D007234:Infant, Premature; D007236:Infant, Small for Gestational Age; D009503:Neutropenia / Q000150:complications; D009504:Neutrophils / Q000187:drug effects; D011994:Recombinant Proteins; D012107:Research Design; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor